Skip to main content
. 2022 Feb 28;26(1):1–16. doi: 10.14701/ahbps.22-009

Table 6.

Summary of randomized controlled trials comparing extended lymph node dissection (LND) and standard LND

Author Comparison group Number Morbidity rate (%)a) p-value Postoperative mortality rate (%) p-value Survival rate (%) p-value
Farnell et al. (2005) [41] Extended
Standard
39
40
N/A NSa) 1 (2.6)
0 (0)
NS 17 (5-yr)
16 (5-yr)
0.320
Nimura et al. (2012) [42] Extended
Standard
50
51
22.0
19.6
NS 1 (2.0)
0 (0)
NS 6.0 (5-yr)
15.7 (5-yr)
0.119
Jang et al. (2014) [43] Extended
Standard
86
83
37 (43.0)
27 (32.5)
0.160 2 (2.3)
0 (0)
NS 35.7 (2-yr)
44.5 (2-yr)
0.122
Jang et al. (2017) [44] Extended
Standard
86
83
N/A - N/A - 14.4 (5-yr)
18.4 (5-yr)
0.388
Ignjatovic et al. (2017) [45] Extended
Standard
30
30
1 (3.3)b)
0 (0)
> 0.05 2 (6.7)
1 (3.3)
> 0.05 7.1 (5-yr)
6.9 (5-yr)
0.057

N/A, not available; NS, not significant.

a)Complications were evaluated separately and not as a whole. There were no differences for all sub-specified complications. b)Postoperative bleeding.